Over the past decade, an increasing number of studies investigated the innovative approach of supplementing cognitive training (CT) with noninvasive brain stimulation (NIBS) to increase the effects on outcomes. In this review, we aim to summarize the evidence for this treatment combination. We identified 72 published and unpublished studies (reporting 773 effect sizes), including 2,518 participants from healthy and clinical populations indexed in PubMed, MEDLINE, APA PsycInfo, ProQuest, Web of Science, and https://ClinicalTrials.gov (last search: August 9, 2022) that compared the effects of NIBS combined with CT on cognitive, symptoms, and everyday functioning to CT alone at postintervention and/or follow-up. We performed random-effects meta-analyses with robust variance estimation and assessed risk of bias with the Cochrane ROB tool. Only four studies had low risk of bias in all domains, and many studies lacked standard controls such as keeping the outcome assessor and trainer unaware of the treatment condition. Following sensitivity analyses, only learning/memory robustly improved significantly more when CT was combined with NIBS compared to CT only (g = 0.18, 95% CI [0.07, 0.29]) at postintervention, but not in the long term. The effect was small and limited by substantial heterogeneity. The other seven cognitive outcome domains, symptoms, and everyday functioning did not benefit from adding NIBS to CT. Given the methodological limitation of prior studies, more high-quality trials that focus on the potential of combining NIBS and CT to enhance benefits in everyday functioning in the short and long term are needed to evaluate whether combining NIBS and CT is relevant for clinical practice. (PsycInfo Database Record (c) 2023 APA, all rights reserved).
8 January 2024 in Social Psychiatry and Psychiatric Epidemiology
Purpose: Living independently, as opposed to in sheltered housing or with caregivers, is an important aim in the recovery of individuals with psychosis, but the transition to independence can be challenging. This study aims to investigate how individuals with psychosis move between living arrangements and to identify the barriers and facilitators of moving towards independence. Methods: The living arrangements of 1119 individuals with non-affective psychosis from the Genetic Risk and Outcome of Psychosis study were assessed at baseline, at three- and six-year follow-ups and further categorized as either supported (sheltered housing or with parents) or independent (single or with partner/family). We estimated the probabilities of transitioning between the living statuses and investigated the influence of demographic characteristics, symptomatology, cognition, social support, and premorbid social adjustment on transition using Markov chain modelling. Results: The majority of individuals living in supported housing remained there during the six-year follow-up period (~ 60%). The likelihood of moving from supported to independent living was twice as high for participants who were younger, five-to-six times higher for women, twice as high for individuals with better overall cognition, and five times higher for those with a course of low positive symptoms. Conclusion: This study highlights that a large group of individuals with psychosis in supported housing is unlikely to move to independent living. Older men with cognitive impairments and who show continuous severe positive symptoms are the least likely to move living independently. Tailored interventions for these at-risk individuals could increase their chances of moving to independent living.
Cognitive impairments are commonly experienced by individuals with severe mental illness (SMI) and are associated with problems in everyday life. This pragmatic, randomized, controlled, pilot trial explored the acceptability, feasibility, and preliminary effects of cognitive remediation (CR) combined with transcranial direct current stimulation (tDCS) for cognitive and everyday functioning in individuals with SMI in long-term psychiatric clinical care. We hypothesized that combining CR and tDCS is feasible and acceptable to individuals with SMI. Twenty-four individuals with SMI were randomized to either CR + active tDCS (n = 13) or CR + sham tDCS (n = 11) over 32 sessions (16 weeks). Acceptability was evaluated in semi-structured interviews. Cognitive and everyday functioning were evaluated at baseline, post-16 week waiting period, post-intervention, and 6-months post-intervention. Overall, participants were positive about the training. Over 60 % of participants successfully finished at least 20 sessions, meeting the predefined criteria for feasibility. CR appeared to yield subjective improvements to participants, significant improvements in cognitive tests post-intervention and at follow-up and improved self-reported negative symptoms at follow-up. Observer-rated everyday functioning and cognition, and subjective cognitive complaints did not change following CR. This study concludes that CR is an acceptable and feasible intervention for individuals with SMI in long-term psychiatric clinical care. The addition of tDCS requires further investigation to ascertain its potential benefits.
Over the past decade, an increasing number of studies investigated the innovative approach of supplementing cognitive training (CT) with non-invasive brain stimulation (NIBS) to increase the effects on outcomes. In this review, we aim to summarize the evidence for this treatment combination. We identified 72 published and unpublished studies (reporting 773 effect sizes) including 2518 participants from healthy and clinical populations indexed in PubMed, Medline, PsycINFO, ProQuest, Web of Science, and ClinicalTrials.gov (last search: 8/8/2022) that compared the effects of NIBS combined with CT on cognitive, symptoms and everyday functioning to CT alone at post-intervention and/or follow-up. We performed random-effects meta-analyses with robust variance estimation and assessed risk of bias with the Cochrane R.O.B. tool. Only four studies had low risk of bias in all domains, and many studies lacked standard controls such as keeping the outcome assessor and trainer unaware of the treatment condition. Following sensitivity analyses, only learning/memory robustly improved significantly more when CT was combined with NIBS compared to CT only (g = 0.18, 95% CI [0.07, 0.29]) at post-intervention, but not in the long-term. The effect was small and limited by substantial heterogeneity. The other seven cognitive outcome domains, symptoms, and everyday functioning did not benefit from adding NIBS to CT. Given the methodological limitation of prior studies, more high-quality trials that focus on the potential of combining NIBS and CT to enhance benefits in everyday functioning in the short- and long-term are needed to evaluate whether combining NIBS and CT is relevant for clinical practice.
24 April 2026 in European Archives of Psychiatry and Clinical Neuroscience
Individuals with severe mental illness (SMI) face daily challenges, often due to cognitive impairments. While cognitive remediation (CR) can improve both cognitive and functional outcomes, especially when combined with other rehabilitation interventions, its effectiveness in individuals with SMI requiring sheltered housing remains unclear. This trial primarily investigates whether CR improves daily and cognitive functioning compared to a waitlist period. As a second exploratory aim, we will examine whether adding transcranial direct current stimulation (tDCS) enhances the effectiveness of CR in a randomised sham-controlled comparison. Lastly, the trial examines participants’ subjective experiences of the CR intervention. We hypothesise improvements in goal attainment, daily functioning, and cognition. Using a non-concurrent multiple baseline design, 126 participants (aged 18–65) with SMI residing in sheltered housing facilities will receive 16–20 weeks of twice-weekly CR sessions lasting 30–45 min, combined with either active ( N = 63) or sham tDCS ( N = 63). Functional, cognitive, and clinical assessments will be conducted at baseline, post-waitlist, post-treatment, and 6-month follow-up. Additionally, participants’ meta-cognitive skills and subjective experiences will be evaluated post-treatment. In multilevel mixed models, we will evaluate the effect of CR (combining both CR groups) vs. waitlist, and compare CR + active tDCS vs. CR + sham tDCS to explore potential augmentation effects. If effective, integrating CR, with or without tDCS, into standard care may benefit recovery in individuals with SMI requiring long-term support. ClinicalTrials.gov: NCT06378463, registered on April 17, 2024.